GT Biopharma Inc. (GTBP) Released a News Update on Monday 3/26/2018. (GTBP) is Announcing Positive Data from its Phase 1 Clinical Trial & The Potential for an Accelerated Start to its Phase 2 Clinical Trial!
For those that have been following GT Biopharma Inc. (GTBP) from the beginning you are aware of the ups and downs the stock has faced, however with the culmination of a management team to rival the “AVENGERS” and the announcement of positive data from their phase 1 clinical trials this could be the spark investors were holding on for.
For those that are unfamiliar with GT Biopharma Inc. (GTBP) & their management team a great place to start is to CLICK HERE
For Those that are familiar and want to read today’s full news release please CLICK HERE
Disclaimer: An affiliate of MarijuanaStocks.com – MIDAM VENTURES LLC., a Florida Corporation that has been compensated $1,800,000.00 by a GT Biopharma Inc. for a period beginning August 1, 2017 and ending April. 30, 2018 to publicly disseminate information about (GTBP). We own zero shares. An affiliate of MarijuanaStocks.com – MIDAM VENTURES LLC., a Florida Corporation that has been compensated $200,000.00 by a GT Biopharma Inc. for a period beginning May 1, 2018 and ending May. 31, 2018 to publicly disseminate information about (GTBP). We own zero shares. Full Disclaimer Here
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
